Full Text (PDF)
Review Article

Insignificance of Variant Analysis in Neuropsychiatric Disorders

Vaishnavi null, Prachi Srivastava

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


International Journal of Neurology and Neurosurgery 16 (3-4 ):p 61-66, July-December 2024. | DOI: https://doi.org/10.21088/ijnns.0975.0223.163424.3

How Cite This Article:

Vaishnavi, Prachi Srivastava, Insignificance of Variant Analysis in Neuropsychiatric Disorders. International Journal of Neurology and Neurosurgery. 2024;16(3-4):61-66.

Timeline

Received : September 26, 2024         Accepted : November 18, 2024          Published : December 30, 2024

Abstract

Neuropsychiatric disorders encompass a wide range of complex disorders where not only the brain of an affected individual but also their behaviour is poorly affected. These disorders include attention deficit hyperactivity disorder (ADHD), eating disorders, Bipolar disorder, Schizophrenia and Autism, arising from the complex interplay of different factors like environment, genetics and epigenetics. Among all genetics plays quite a significant role in the progression of these disorders. Genetic variants like SNPs, CNVs and genetic mutations are important in influencing the progression of these disorders. Several technologies such as Genome-wide association studies can be used to identify the key gene loci and pathways for the progression of neuropsychiatric disorders. This article aims to have an overview of all genetic variants of various neuropsychiatric conditions with an understanding of their pathways. Moreover, it also highlights different techniques that are used in finding these key gene variants. Also, the complexities that create challenges to genetic variant analysis for medical relevance and how upcoming technologies be used to overcome this problem.


References

  • 1.   Taslim S, Shadmani S, Saleem AR, Kumar A, Brahma F, Blank N, et al. Neuropsychiatric Disorders: Bridging the Gap Between Neurology and Psychiatry. Cureus [Internet]. 2024 Jan 4;16(1):e51655. Available from: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC10838116/
  • 2.   National Institutes of Health. Common genetic factors found in 5 mental disorders [Internet]. National Institutes of Health. 2013. Available from: https://www.nih.gov/news-events/nih-researchmatters/common-genetic-factors-found-5-mentaldisorders
  • 3.   Mitrea L, Nemeş SA, Szabo K, Teleky BE, Vodnar DC. Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders. Frontiers in Medicine [Internet]. 2022 Mar 31;9:813204. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC9009523/
  • 4.   Pettersson E, Lichtenstein P, Larsson H, Song J, Agrawal A, Børglum AD, et al. Genetic Influences on Eight Psychiatric Disorders Based on Family Data of 4 408 646 Full and half-siblings, and Genetic Data of 333 748 Cases and Controls. Psychological Medicine [Internet]. 2018 Sep 17;49(07):1166–73. Available from: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC6421104/
  • 5.   Parenti I, Rabaneda LG, Schoen H, Novarino G. Neurodevelopmental Disorders: From Genetics to Functional Pathways. Trends in Neurosciences. 2020 Aug 1;43(8):608–21.
  • 6.   Kaufmann WE, Kidd SA, Andrews HF, Budimirovic DB, Esler A, Haas-Givler B, et al. Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment. Pediatrics [Internet]. 2017 Jun;139(Supplement 3):S194–206. Available from: https://pediatrics.aappublications. org/content/139/Supplement_3/S194
  • 7.   Bassett AS, Chow EWC. Schizophrenia and 22q11.2 deletion syndrome. Current Psychiatry Reports. 2008 Apr;10(2):148–57.
  • 8.   Jiang S, Postovit L, Cattaneo A, Binder EB, Aitchison KJ. Epigenetic Modifications in Stress Response Genes Associated with Childhood Trauma. Frontiers in Psychiatry [Internet]. 2019 Nov 8;10(808). Available from: https://www. frontiersin.org/articles/10.3389/fpsyt.2019.00808/ full
  • 9.   Rees E, Owen MJ. Translating insights from neuropsychiatric genetics and genomics for precision psychiatry. Genome Medicine. 2020 Apr 29;12(1).
  • 10.   Marian AJ. Clinical Interpretation and Management of Genetic Variants. JACC: Basic to Translational Science. 2020 Oct;5(10):1029–42.
  • 11.   Harrison PJ. Recent genetic findings in schizophrenia and their therapeutic relevance. Pratt J, editor. Journal of Psychopharmacology [Internet]. 2014 Oct 14;29(2):85–96. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4361495/
  • 12.   Medline Plus. What is a gene mutation and how do mutations occur?: MedlinePlus Genetics [Internet]. medlineplus.gov. 2020. Available from: https:// medlineplus.gov/genetics/understanding/ mutationsanddisorders/genemutation/
  • 13.   MedlinePlus. What Are Single Nucleotide Polymorphisms (SNPs)? [Internet]. medlineplus. gov. National Library of Medicine; 2022. Available from: https://medlineplus.gov/genetics/ understanding/genomicresearch/snp/
  • 14.   Bray NJ, O’Donovan MC. The genetics of neuropsychiatric disorders. Brain and Neuroscience Advances [Internet]. 2018 Oct 12;2. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC6551216/
  • 15.   Copy Number Variation and Genetic Disease | Learn Science at Scitable [Internet]. www.nature. com. Available from: https://www.nature.com/ scitable/topicpage/copy-number-variation-andgenetic-disease-911/
  • 16.   Lin M, Whitmire S, Chen J, Farrel A, Shi X, Guo J. Effects of short indels on protein structure and function in human genomes. Scientific Reports [Internet]. 2017 Aug 24;7(1):9313. Available from: https://www.nature.com/articles/s41598-017-09287-x#:~:text=Indels%20in%20coding%20 regions%20can
  • 17.   Lee JA, Lupski JR. Genomic Rearrangements and Gene Copy-Number Alterations as a Cause of Nervous System Disorders. Neuron. 2006 Oct;52(1):103–21.
  • 18.   World Health Organization (WHO). Schizophrenia [Internet]. World Health Organization. World Health Organization; 2022. Available from: https://www.who.int/news-room/fact-sheets/ detail/schizophrenia
  • 19.   Mayo Clinic. Schizophrenia - symptoms and causes [Internet]. Mayo Clinic. 2024. Available from: https://www.mayoclinic.org/diseasesconditions/schizophrenia/symptoms-causes/syc- 20354443
  • 20.   Ebrahimi M, Teymouri K, Chen CC, Mohiuddin AG, Pouget JG, Goncalves VF, et al. Association study of the complement component C4 gene and suicide risk in schizophrenia. Schizophrenia [Internet]. 2024 Feb 10;10(1):1–9. Available from: https://www.nature.com/articles/s41537-024- 00440-w#:~:text=Specifically%2C%20in%20the%20 context%20of
  • 21.   Oda Y, Kawahara N, Iyo M. Alterations of Dopamine D2 Receptors and Related Receptor-Interacting Proteins in Schizophrenia: The Pivotal Position of Dopamine Supersensitivity Psychosis in TreatmentResistant Schizophrenia. International Journal of Molecular Sciences. 2015 Dec 17;16(12):30144–63.
  • 22.   Bigos KL, Mattay VS, Callicott JH, Straub RE, Vakkalanka R, Kolachana B, et al. Genetic Variation in CACNA1C Affects Brain Circuitries Related to Mental Illness. Archives of General Psychiatry [Internet]. 2010 Sep 1 [cited 2019 Jun 10];67(9):939. Available from: https://jamanetwork.com/ journals/jamapsychiatry/article-abstract/210875
  • 23.   22q11.2 deletion syndrome: MedlinePlus Genetics [Internet]. medlineplus.gov. 2019. Available from: https://medlineplus.gov/genetics/ condition/22q112-deletion-syndrome/
  • 24.   Bassett AS, Chow EWC. 22q11 deletion syndrome: a genetic subtype of schizophrenia. Biological Psychiatry. 1999 Oct;46(7):882–91.
  • 25.   Wang S, Rhijn JR van, Akkouh I, Kogo N, Maas N, Bleeck A, et al. Loss-of-function variants in the schizophrenia risk gene SETD1A alter neuronal network activity in human neurons through the cAMP/PKA pathway. Cell Reports [Internet]. 2022 May 3 [cited 2023 Nov 5];39(5):110790. Available from: https://pubmed.ncbi.nlm.nih. gov/35508131/
  • 26.   Wu T, Cai W, Chen X. Epigenetic regulation of neurotransmitter signalling in neurological disorders. Neurobiology of Disease [Internet]. 2023 Aug 1;184:106232. Available from: https:// www.sciencedirect.com/science/article/pii/ S0969996123002474
  • 27.   Zoghbi HY, Bear MF. Synaptic Dysfunction in Neurodevelopmental Disorders Associated with Autism and Intellectual Disabilities. Cold Spring Harbor Perspectives in Biology. 2012 Jan 18;4(3):a009886–6.
  • 28.   Mayo Clinic. Bipolar disorder [Internet]. Mayo Clinic. 2024. Available from: https://www. mayoclinic.org/diseases-conditions/bipolardisorder/symptoms-causes/syc-20355955
  • 29.   Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience [Internet]. 2009 Nov;164(1):331–43. Available from: https://www. ncbi.nlm.nih.gov/pmc/articles/PMC3637882/
  • 30.   Bhat S, Dao DT, Terrillion CE, Arad M, Smith RJ, Soldatov NM, et al. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Progress in neurobiology [Internet]. 2012 Oct 1 [cited 2020 Jun 26];99(1):1–14. Available from: https://www.ncbi. nlm.nih.gov/pmc/articles/PMC3459072/
  • 31.   The. GRIN2A-Related Disorders [Internet]. Chop. edu. 2014 [cited 2024 Dec 24]. Available from: https://www.chop.edu/conditions-diseases/ grin2a-related-disorders
  • 32.   Green EK, Rees E, Walters JTR, Smith K-G, Forty L, Grozeva D, et al. Copy number variation in bipolar disorder. Molecular Psychiatry. 2015 Jan 6;21(1):89– 93.
  • 33.   McCarthy MJ, Gottlieb JF, Gonzalez R, McClung CA, Alloy LB, Cain S, et al. Neurobiological and behavioural mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi‐ disciplinary literature review and agenda for future research from the ISBD task force on chronobiology. Bipolar Disorders. 2021 Dec 10;
  • 34.   Fachim HA, Corsi-Zuelli F, Loureiro CM, Iamjan S, Shuhama R, Joca S, et al. Early-life stress effects on BDNF DNA methylation in first-episode psychosis and rats reared in isolation. Progress in NeuroPsychopharmacology and Biological Psychiatry [Internet]. 2021 Jun 8;108:110188. Available from: https://www.sciencedirect.com/science/article/ pii/S0278584620305042?via%3Dihub#bb0255
  • 35.   Serretti A. Precision medicine in mood disorders. Psychiatry and Clinical Neurosciences Reports. 2022 Feb 19;1(1).
  • 36.   National Institute of Mental Health. Anxiety disorders [Internet]. National Institute of Mental Health. 2024. Available from: https://www.nimh. nih.gov/health/topics/anxiety-disorders
  • 37.   Santoro M, Siotto M, Germanotta M, Mastrorosa A, Papadopoulou D, Aprile I. Association Study of SLC6A4 (5-HTTLPR) Polymorphism and Its Promoter Methylation with Rehabilitation Outcome in Patients with Subacute Stroke. Genes. 2021 Apr 16;12(4):579.
  • 38.   Sheikh HI, Kryski KR, Smith HJ, Dougherty LR, Klein DN, Bufferd SJ, et al. Catechol-OMethyltransferase gene val158met polymorphism and depressive symptoms during early childhood. American Journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics [Internet]. 2013 Apr 1 [cited 2022 Nov 16];162B(3):245–52. Available from: https://www. ncbi.nlm.nih.gov/pmc/articles/PMC5288403/
  • 39.   Lee LO, Prescott CA. Association of the catecholO-methyltransferase val158met polymorphism and anxiety-related traits. Psychiatric Genetics. 2014 Apr;24(2):52–69.
  • 40.   Laryea G, Arnett MG, Muglia LJ. Behavioural Studies and Genetic Alterations in CorticotropinReleasing Hormone (CRH) Neurocircuitry: Insights into Human Psychiatric Disorders. Behavioral Sciences. 2012 Jun 21;2(2):135–71.
  • 41.   Enoch MA, Schwartz L, Albaugh B, Virkkunen M, Goldman D. Dimensional anxiety mediates linkage of ofGABRA2 haplotypes with alcoholism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2006;141B(6):599–607.
  • 42.   Saus E, Brunet A, Armengol L, Alonso P, Crespo JL, Fernández-Aranda F, et al. Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. 2010 Oct 1;44(14):971– 8.
  • 43.   Dedic N, Pöhlmann ML, Richter JS, Mehta D, Czamara D, Metzger MW, et al. Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. Molecular Psychiatry [Internet]. 2017 Jul 11 [cited 2019 Nov 27];23(3):533– 43. Available from: https://www.ncbi.nlm.nih. gov/pmc/articles/PMC5822460/
  • 44.   Mahdi Malekpour, Dorsa Shekouh, Mohammad Ebrahim Safavinia, Shadi Shiralipour, Jalouli M, Sahar Mortezanejad, et al. Role of FKBP5 and its genetic mutations in stress-induced psychiatric disorders: an opportunity for drug discovery. Frontiers in Psychiatry. 2023 Jun 16;14.
  • 45.   Libert S, Pointer KB, Bell EF, Das A, Cohen D, Asara JM, et al. SIRT1 Activates MAO-A in the Brain to Mediate Anxiety and Exploratory Drive. Cell. 2011 Dec 23;147(7):1459–72.
  • 46.   Booij L, Wang D, Lévesque M, Tremblay R, Szyf M. Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress–diathesis model of depression. Philosophical Transactions of the Royal Society B: Biological Sciences [Internet]. 2013; Available from: https:// www.semanticscholar.org/paper/Lookingbeyond-the-DNA-sequence%3A-the-relevance-ofBooij-Wang/eccbe750fc6f0e995f209f40aca334ff1 3b01152
  • 47.   Gottschalk MG, Domschke K. Genetics of generalized anxiety disorder and related traits. Dialogues in Clinical Neuroscience. 2017 Jun;19(2):159–68.
  • 48.   Gutiérrez-Rodríguez A, Cruz-Fuentes CS, GenisMendoza AD, Nicolini H. CRISPR/Cas9 Genome Editing Approaches for Psychiatric Research. Brazilian Journal of Psychiatry [Internet]. 2023;45(2). Available from: https://www.scielo.br/j/rbp/a/3 6qPg7qLMBdSfp3BYTfNGJs/?format=pdf&lang= en
  • 49.   Łoś K, Waszkiewicz N. Biological Markers in Anxiety Disorders. Journal of Clinical Medicine [Internet]. 2021 Apr 17;10(8):1744. Available from: https://www.mdpi.com/2077-0383/10/8/1744

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Vaishnavi, Prachi Srivastava, Insignificance of Variant Analysis in Neuropsychiatric Disorders. International Journal of Neurology and Neurosurgery. 2024;16(3-4):61-66.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
September 26, 2024 November 18, 2024 December 30, 2024

DOI: https://doi.org/10.21088/ijnns.0975.0223.163424.3

Keywords

Neuropsychiatric disordersBipolar disorderSchizophreniaAnxietyCRISPR-Cas9omicsgene lociSNPsCNVs and Genome-wide association studies (GWAS)

Article Level Metrics

Last Updated

Monday 23 November 2026, 00:42:11 (IST)


3630

Accesses

12
424
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received September 26, 2024
Accepted November 18, 2024
Published December 30, 2024

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share